JUNS

Jupiter Neurosciences
$0.11
−$0.01 (−5.79%)Jul 27, 2026
0.4PoorMoatMint rating

MoatMint rates Jupiter Neurosciences (JUNS) 0.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.7 out of 10.

Key metrics

The numbers that frame JUNS today
Market cap
$4.14M
P/E (TTM)
-0.5
EV / FCF
-1.1
Gross margin
78.8%
EV / Sales
163.3
ROIC
2,487.4%
Div yield
0%
52wk Low
$0.11
52wk High
$1.84

JUNS stock rating

How JUNS scores on quality, value, growth, momentum and financial health
0.4out of 10
Low overallNeutral business, expensive priceTop 96% of ~5,000 US stocks
QualityPoor1.7/10
GrowthGood6.4/10
MomentumPoor0.3/10
ValuePoor0.3/10
Financial HealthPoor0.3/10

Growth

Revenue and earnings trend for JUNS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about JUNS
Is Jupiter Neurosciences a good buy?
No. Jupiter Neurosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Jupiter Neurosciences is selling at a very high price.
What is the market capitalization of JUNS?
Jupiter Neurosciences's market capitalization is $4.14M.
What is the P/E ratio for JUNS stock?
Jupiter Neurosciences's current P/E ratio is -0.5.
What is the 52-week high for JUNS stock?
The 52-week high for Jupiter Neurosciences is $1.84. The current close of $0.11 is 93.8% below that high.
What is the 52-week low for JUNS stock?
The 52-week low for Jupiter Neurosciences is $0.11. The current close of $0.11 is 6.5% above that low.
Does JUNS stock pay dividends?
Jupiter Neurosciences does not currently show a dividend per share in the company data.